Actual Medicinal Product (AMP) Trazodone 150mg tablets (Alliance Healthcare (Distribution) Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Light sensitive medicine. Store in light resistant container. Moisture sensitive medicine. Store in airtight (sealed) MCA. Manufacturer recommends storing in original container.
Anecdotal reports of use in MCAs for up to 4 weeks (low quality evidence). - Provenance
-
This recommendation is based on the products Molipaxin 150mg tablets (Zentiva) and trazodone 150mg tablets (Accord Healthcare Limited).
- Generic
- Trazodone
- Formulation
- Trazodone 150mg tablets
-
Trazodone
-
Trazodone 150mg tablets
-
Trazodone 150mg tablets (Alliance Healthcare (Distribution) Ltd)
-
-
Trazodone 150mg modified-release tablets